Cargando…
Population Pharmacokinetic Analysis to Assist Dose Selection of the l-Ornithine Salt of Phenylacetic Acid
BACKGROUND AND OBJECTIVE: l-Ornithine phenylacetate is an intravenous formulation of the l-ornithine salt of phenylacetic acid under development for the treatment of hepatic encephalopathy. Very limited clinical data in patients are available, with a phase II study in target patients not designed fo...
Autores principales: | Wang, Xiaofeng, Vilchez, Regis A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975757/ https://www.ncbi.nlm.nih.gov/pubmed/34786649 http://dx.doi.org/10.1007/s40262-021-01075-1 |
Ejemplares similares
-
Exposures of Phenylacetic Acid and Phenylacetylglutamine Across Different Subpopulations and Correlation with Adverse Events
por: Wang, Xiaofeng, et al.
Publicado: (2021) -
Pharmacokinetics/pharmacodynamics of L‐ornithine phenylacetate in overt hepatic encephalopathy and the effect of plasma ammonia concentration reduction on clinical outcomes
por: Safadi, Rifaat, et al.
Publicado: (2022) -
Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patients
por: Ventura-Cots, Meritxell, et al.
Publicado: (2016) -
Pharmacokinetic and Pharmacodynamic Properties of l-Ornithine l-Aspartate (LOLA) in Hepatic Encephalopathy
por: Kircheis, Gerald, et al.
Publicado: (2019) -
Chemoenzymatic Epoxidation of Alkenes and Reusability Study of the Phenylacetic Acid
por: Abdulmalek, Emilia, et al.
Publicado: (2014)